| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $734,281 ) |
| | 2024 | 2024 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44AI157022 | Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem | 000 | 3 | NIH | 5/1/2024 | $752,527 |
| | 2024 | 2021 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R43AI157022 | Rapid identification and selection of functional antigen-specific monoclonal antibodies by FcGR-enabled screening on CytoSort Arrays in the CellRaft AIR System | 000 | 1 | NIH | 11/15/2023 | $0 |
| | 2024 | 2021 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R43GM143978 | Improving iPSC reprogramming and CRISPR gene editing workflows and efficacy using CellRaft technology | 000 | 1 | NIH | 4/12/2024 | $0 |
| | 2024 | 2021 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44ES032782 | Three-dimensional organoid culture using the CellRaft microwell technology | 000 | 3 | NIH | 4/15/2024 | -$18,246 |
|
| Issue Date FY: 2023 ( Subtotal = $838,127 ) |
| | 2023 | 2023 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44AI157022 | Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem | 002 | 2 | NIH | 6/13/2023 | -$838,127 |
| | 2023 | 2023 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44AI157022 | Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem | 002 | 2 | NIH | 6/13/2023 | $838,127 |
| | 2023 | 2023 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44AI157022 | Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem | 001 | 2 | NIH | 6/12/2023 | -$838,127 |
| | 2023 | 2023 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44AI157022 | Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem | 000 | 2 | NIH | 5/17/2023 | $838,127 |
| | 2023 | 2023 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44AI157022 | Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem | 001 | 2 | NIH | 6/12/2023 | $838,127 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | CELL MICROSYSTEMS INC | 801 CAPITOLA DR | DURHAM | NC | 27713-4384 | DURHAM | USA | R44GM134993 | High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array | 000 | 3 | NIH | 8/28/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,127,596 ) |
| | 2021 | 2021 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R43GM143978 | Improving iPSC reprogramming and CRISPR gene editing workflows and efficacy using CellRaft technology | 000 | 1 | NIH | 7/20/2021 | $256,605 |
| | 2021 | 2021 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R44ES032782 | Three-dimensional organoid culture using the CellRaft microwell technology | 000 | 3 | NIH | 7/20/2021 | $599,959 |
| | 2021 | 2021 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R43AI157022 | Rapid identification and selection of functional antigen-specific monoclonal antibodies by FcGR-enabled screening on CytoSort Arrays in the CellRaft AIR System | 000 | 1 | NIH | 12/31/2020 | $292,047 |
| | 2021 | 2019 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R44HG010003 | Fully integrated single cell imaging and RNA-Seq library preparation | 000 | 3 | NIH | 3/12/2021 | -$21,015 |
| | 2021 | 2019 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R43GM133300 | Three-dimensional organoid culture using the CellRaft microwell technology | 000 | 1 | NIH | 5/16/2021 | $0 |
| | 2021 | 2019 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R41GM131475 | Automated CRISPR Screening Using the CellRaft Technology | 000 | 1 | NIH | 5/16/2021 | $0 |
| | 2021 | 2018 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R42AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 000 | 3 | NIH | 2/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,453,788 ) |
| | 2020 | 2020 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R44ES032782 | Three-dimensional organoid culture using the CellRaft microwell technology | 000 | 2 | NIH | 8/1/2020 | $633,892 |
| | 2020 | 2020 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R44GM134993 | High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array | 001 | 3 | NIH | 4/17/2020 | $819,896 |
| | 2020 | 2019 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R41GM131475 | Automated CRISPR Screening Using the CellRaft Technology | 000 | 1 | NIH | 5/11/2020 | $0 |
| | 2020 | 2019 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R44GM134993 | High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array | 000 | 2 | NIH | 1/16/2020 | $0 |
| | 2020 | 2018 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R44GM119888 | Automated Isolation of Single Cells Using High-Resolution and Subcellular Imaging | 000 | 3 | NIH | 7/6/2020 | $0 |
| | 2020 | 2017 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R41HG009467 | High throughput CRISPR/Cas9 cell line generation using the CellRaft Array platform | 000 | 1 | NIH | 6/23/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $2,189,560 ) |
| | 2019 | 2019 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R44HG010003 | Fully integrated single cell imaging and RNA-Seq library preparation | 000 | 3 | NIH | 11/28/2018 | $809,201 |
| | 2019 | 2019 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R44GM134993 | High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array | 000 | 2 | NIH | 4/8/2019 | $813,352 |
| | 2019 | 2019 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R41GM131475 | Automated CRISPR Screening Using the CellRaft Technology | 000 | 1 | NIH | 12/26/2018 | $267,489 |
| | 2019 | 2019 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R43GM133300 | Three-dimensional organoid culture using the CellRaft microwell technology | 000 | 1 | NIH | 5/28/2019 | $300,161 |
| | 2019 | 2017 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R42GM106421 | The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and Recovery | 000 | 3 | NIH | 5/3/2019 | $0 |
| | 2019 | 2017 | CELL MICROSYSTEMS, INC. | 801 CAPITOLA DR STE 10 | DURHAM | NC | 27713-4384 | DURHAM | USA | R42GM106421 | The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and Recovery | 001 | 3 | NIH | 7/9/2019 | -$643 |
|
| Issue Date FY: 2018 ( Subtotal = $2,305,296 ) |
| | 2018 | 2018 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R44GM119888 | Automated Isolation of Single Cells Using High-Resolution and Subcellular Imaging | 000 | 3 | NIH | 3/13/2018 | $768,019 |
| | 2018 | 2018 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R44HG010003 | Fully integrated single cell imaging and RNA-Seq library preparation | 000 | 2 | NIH | 12/15/2017 | $735,660 |
| | 2018 | 2018 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R42AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 001 | 3 | NIH | 6/22/2018 | $801,617 |
| | 2018 | 2017 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R42AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 000 | 2 | NIH | 11/6/2017 | $2,015 |
| | 2018 | 2016 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R41AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 000 | 1 | NIH | 11/6/2017 | -$2,015 |
|
| Issue Date FY: 2017 ( Subtotal = $2,669,175 ) |
| | 2017 | 2017 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R41HG009467 | High throughput CRISPR/Cas9 cell line generation using the CellRaft Array platform | 000 | 1 | NIH | 4/28/2017 | $250,780 |
| | 2017 | 2017 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R42GM106421 | The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and Recovery | 000 | 3 | NIH | 1/26/2017 | $798,505 |
| | 2017 | 2017 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R42AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 000 | 2 | NIH | 7/3/2017 | $801,389 |
| | 2017 | 2017 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R44GM119888 | Automated Isolation of Single Cells Using High-Resolution and Subcellular Imaging | 000 | 2 | NIH | 2/28/2017 | $818,501 |
| | 2017 | 2016 | CELL MICROSYSTEMS, INC. | 2 DAVIS DRIVE ROOM 119 AND 118 | RESEARCH TRIANGLE PARK | NC | 27709-0003 | DURHAM | USA | R41AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 000 | 1 | NIH | 6/28/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $972,784 ) |
| | 2016 | 2016 | CELL MICROSYSTEMS INC | 907 GREENWOOD ROAD | CHAPEL HILL | NC | 27514 | ORANGE | USA | R42GM106421 | The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and Recovery | 000 | 2 | NIH | 1/27/2016 | $748,655 |
| | 2016 | 2016 | CELL MICROSYSTEMS INC | 907 GREENWOOD ROAD | CHAPEL HILL | NC | 27514 | ORANGE | USA | R41AI126905 | CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells | 000 | 1 | NIH | 6/16/2016 | $224,129 |
|
|
